Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-020547

Chief Operating Officer bought 36,000 shares at an average $0.91 ($32,894)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Cittadine Andrew Chief Operating Officer 2024-06-13 Purchase +12,000 $0.91 $10,920 129,624 D
Cittadine Andrew Chief Operating Officer 2024-06-14 Purchase +12,000 $0.93 $11,176 141,624 D
Cittadine Andrew Chief Operating Officer 2024-06-17 Purchase +12,000 $0.90 $10,799 153,624 D
Open-market purchases · 36,000 sh · avg $0.91 · $32,894
Loading xslF345X05/rdgdoc.xml…